Intravitreal inhibition of complement C5a reduces choroidal neovascularization in mice.
about
Fit for the Eye: Aptamers in Ocular DisordersAnti-complement component 5 antibody targeting MG4 domain inhibits choroidal neovascularization.Spatial distribution of CD115+ and CD11b+ cells and their temporal activation during oxygen-induced retinopathy in mice.Effect of Anti-C5a Therapy in a Murine Model of Early/Intermediate Dry Age-Related Macular Degeneration.
P2860
Intravitreal inhibition of complement C5a reduces choroidal neovascularization in mice.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Intravitreal inhibition of complement C5a reduces choroidal neovascularization in mice.
@ast
Intravitreal inhibition of complement C5a reduces choroidal neovascularization in mice.
@en
type
label
Intravitreal inhibition of complement C5a reduces choroidal neovascularization in mice.
@ast
Intravitreal inhibition of complement C5a reduces choroidal neovascularization in mice.
@en
prefLabel
Intravitreal inhibition of complement C5a reduces choroidal neovascularization in mice.
@ast
Intravitreal inhibition of complement C5a reduces choroidal neovascularization in mice.
@en
P2093
P2860
P1476
Intravitreal inhibition of complement C5a reduces choroidal neovascularization in mice.
@en
P2093
Antonia M Joussen
Axel Vater
Catharina Busch
Claudia Brockmann
Norbert Kociok
Olaf Strauß
Sabrina Dege
Sven Klussmann
Tobias Brockmann
P2860
P2888
P304
P356
10.1007/S00417-015-3041-Z
P577
2015-05-16T00:00:00Z